JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.


Figure 5


FIGURE 5.  (A) Doxycycline-mediated inhibition of HSV1-TK messenger RNA for NG4TL4/tet-off-HSV1-TK cells, NG4TL4/tet-off-mNLSHSV1-TK cells, and NG4TL4/tet-off-mNLSHSV1-TK:dMODC cells. (B) Doxycycline-mediated inhibition of HSV1-TK enzyme activity for NG4TL4/tet-off-HSV1-TK cells, NG4TL4/tet-off-mNLSHSV1-TK cells, and NG4TL4/tet-off-mNLSHSV1-TK:dMODC cells. Stably transformed cell lines were treated with 0, 0.01, 0.1, 1, and 10 ng of doxycycline per milliliter. After doxycycline treatment, changes in messenger RNA levels and enzyme activity of HSV1-TK were assayed at various time points using real-time PCR and in vitro assay for HSV1-TK enzyme activity, respectively. Bars represent mean ± SD of 3 independent experiments.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE